Detection of human papillomavirus among women in laos: Feasibility of using filter paper card and prevalence of high-risk types

International Journal of Gynecological Cancer

Volumn 22, Issue 8, 2012, Pages 1398-1406

  Phongsavan, Keokedthong ^a,b   Gustavsson, Inger ^c   Marions, Lena ^a   Phengsavanh, Alongkone ^d   Wahlstrom, Rolf ^e   Gyllensten, Ulf ^c  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b Sethathirath Hospital   (Laos)

^c UPPSALA UNIVERSITY   (Sweden)

^d UNIVERSITY OF HEALTH SCIENCES   (Laos)

^e KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Cervical cancer; FTA card; High risk types; Human papillomavirus; Laos

Indexed keywords

GENOMIC DNA; VIRUS DNA; WART VIRUS VACCINE;

ADULT; ARTICLE; CANCER PREVENTION; CROSS-SECTIONAL STUDY; FEASIBILITY STUDY; FEMALE; FILTER PAPER CARD; GYNECOLOGICAL EXAMINATION; HEALTH CARE PLANNING; HIGH RISK POPULATION; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; HUMAN PAPILLOMAVIRUS TYPE 33; HUMAN PAPILLOMAVIRUS TYPE 45; HUMAN PAPILLOMAVIRUS TYPE 52; HUMAN PAPILLOMAVIRUS TYPE 58; LAOS; MAJOR CLINICAL STUDY; NONHUMAN; PAPILLOMAVIRUS INFECTION; PREVALENCE; PRIMARY PREVENTION; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; SECONDARY PREVENTION; TEST STRIP; TROPIC CLIMATE; UTERINE CERVIX CANCER; VIRUS DETECTION; VIRUS TYPING; WART VIRUS;

ADOLESCENT; ADULT; CERVIX UTERI; CHILD; CROSS-SECTIONAL STUDIES; DNA, VIRAL; FEASIBILITY STUDIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; LAOS; MIDDLE AGED; NEOPLASM STAGING; PAPER; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PATIENT IDENTIFICATION SYSTEMS; PREVALENCE; PROGNOSIS; REAL-TIME POLYMERASE CHAIN REACTION; RISK FACTORS; SPECIMEN HANDLING; UTERINE CERVICAL NEOPLASMS; VAGINAL SMEARS; YOUNG ADULT;

EID: 84867263981     PISSN: 1048891X     EISSN: 15251438     Source Type: Journal    
DOI: 10.1097/IGC.0b013e3182664b6b     Document Type: Article

References (26)

1. Peto J, Gilham C, Fletcher O, et al. The cervical cancer epidemic that screening has prevented in the UK. Lancet. 2004;364:249-956.
2. Parkin DM, Bray F, Ferlay J, et al. Global cancer statistics
3. CA Cancer J Clin. 2005;55:74-108.
4. Walboomers JM, Jacobs MV, Manos MM, et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol. 1999;189:12-19.
5. Schiffman M, Castle PE, Jeronimo J, et al. Human papillomavirus and cervical cancer. Lancet. 2007;370:890-907.
6. Vientiane: National Institute of Public Health, Ministry of Health. National Health Survey (2006) Health Status of Lao PDR.
7. WHO/Lao PDR (2008) Country Profile. Available at http:/www3.alliance- hpsr.org/countries/2008/Lao/en/. Accessed March 25, 2011.
8. WHO/ICO (2010) Summary report on HPV and cervical cancer statistics in Laos 2010. Geneva: HPV Information Centre. Available at www.who.int/hpvcentre. Accessed July 17, 2011.
9. National Statistics Centre of the Lao PDR. Chapter 1. Population size and composition. Population census 2005. Vientiane, Laos. Available at http:/www.nsc.gov.la. Accessed March 25, 2011.
10. Phongsavan K, Phengsavanh A, Wahlstrom R, et al. Safety, feasibility, and acceptability of visual inspection with acetic acid and immediate treatment with cryotherapy in rural Laos. Int J Gyn Obstet. 2011;114:268-272.
11. Gustavsson I, Lindell M, Wilander E, et al. Use of FTA card for dry collection, transportation and storage of specimen to detect high-risk HPV. J Clin Virol. 2009;46:112-116.
12. Gustavsson I, Juko-Pecirep I, Backlund I, et al. Comparison between the Hybrid Capture 2 and the hpVIR real-time PCR for detection of human papillomavirus in women with ASCUS or low grade dysplasia. J Clin Virol. 2009;45:85-89.
13. Kailach U, Hedau S, Gopalkrishna V, et al. A simple 'paper smear' method for dry collection, transport and storage of cervical cytological specimens for rapid screening of HPV infection by PCR. J Med Microbiol. 2002;51:606-610.
14. Banura C, Franceschi S, van Doorn LJ, et al. Detection of cervical human papillomavirus infection in filter paper samples: a comparative study. J Med Microbiol. 2009;57:253-255.
15. Pham TH, Nguyen TH, Herrero R, et al. Human papillomavirus infection among women in South and North Vietnam. Int J Cancer. 2003;104:213-220.
16. Ye J, Cheng X, Chen X, et al. Prevalence and risk profile of cervical Human papillomavirus infection in Zhejiang Province, southeast China: a population-based study. Virol J. 2010;7:66. Available at http://www.virologyj. com/ content/7/1/66.
17. Sukvirach S, Smith JS, Tunsakul S, et al. Population-based human papillomavirus prevalence in Lampang and Songkla, Thailand. J Infect Dis. 2003;187:1246-1256.
18. Shin HR, Lee DH, Herrero R, et al. Prevalence of human papillomavirus infection in women in Busan, South Korea. Int J Cancer. 2003;103:413-421.
19. Vet JN, de Boer MA, van den Akker BE, et al. Prevalence of human papillomavirus in Indonesia: a population-based study in three regions. Br J Cancer. 2008;99:214-218.
20. Franceschi S, Rajkumar R, Snijders PJ, et al. Papillomavirus infection in rural women in southern India. Br J Cancer. 2005;92:60-606.
21. de Sanjose S, Diaz M, Castellsague X, et al. Worldwide prevalence and genotype distribution of cervical human papillomavirus DNA in women with normal cytology: a meta-analysis. Lancet Infect Dis. 2007;7:453-459.
22. Bao YP, Li N, Smith JS, et al. Human papillomavirus type distribution in women from Asia: a meta-analysis. Int J Gynecol Cancer. 2008;18:71-79.
23. Peto J, Gilham C, Deacon J, et al. Cervical HPV infection and neoplasia in a large population-based prospective study: the Manchester cohort. Br J Cancer. 2004;91:942-953.
24. Stanley M. Immune responses to human papillomavirus. Vaccine. 2006;24:S16YS22.
25. Franco EL, Villa LL, Sobrinho JP, et al. Epidemiology of acquisition and clearance of cervical human papillomavirus infection in women from a high-risk area for cervical cancer. J Infect Dis. 1999;180:1415-1423.
26. Bae J, Seo SS, Park YS, et al. Natural history of persistent high-risk human papillomavirus infections in Korean women. Gynecol Oncol. 2009;115:75-80.